Promises
1 promise
Promise Tracker
0 delivered, 0 close, 1 missed.
View Promises →
Godrej Consumer Products Limited — Q2 FY24
GCPL reported Q2 FY24 organic volume growth of 6% and revenue growth of 2%, with EBITDA up 30% YoY.
neutral
medium
✓ Verified against BSE filing
2-Minute Summary
✦ AI-Generated from Full Transcript
GCPL reported Q2 FY24 organic volume growth of 6% and revenue growth of 2%, with EBITDA up 30% YoY. India volumes grew 11% but missed expectations due to poor household insecticide performance from erratic monsoons and a surprise second Shravan month impacting hair color. Indonesia delivered strong 11% volume growth driven by improved product efficacy. The Raymond Consumer integration is complete, with record September sales and 30% overhead reduction. Management expects steady margin improvement from structural cost savings and plans to reorganize East African hair fashion to an asset-light royalty model, targeting ~INR 50 crore profit on zero revenue. Key risks include continued demand weakness in mass segments and potential competitive pressure in soaps from local players.
GCPL ने दूसरी तिमाही में अपने कारोबार की असली बढ़त 6% दिखाई, जबकि कुल कमाई में 2% का इज़ाफा हुआ। मुनाफा (EBITDA) पिछले साल के मुकाबले 30% बढ़ा। भारत में बिक्री 11% बढ़ी, लेकिन उम्मीद से कम रही क्योंकि बारिश के अनियमित होने से कीटनाशकों की बिक्री घटी और दूसरे श्रावण मास के कारण बालों के रंग की मांग कम हुई। इंडोनेशिया में प्रोडक्ट की गुणवत्ता सुधरने से बिक्री 11% बढ़ी। रेमंड कंज्यूमर का विलय पूरा हो गया है, सितंबर में रिकॉर्ड बिक्री हुई और खर्च 30% कम हुए। कंपनी लागत बचत से मुनाफा बढ़ाने की योजना बना रही है और पूर्वी अफ्रीका में बालों के फैशन कारोबार को नए मॉडल पर चलाएगी, जिससे बिना कमाई के करीब 50 करोड़ रुपये मुनाफा होगा। जोखिम: सस्ते उत्पादों की कमजोर मांग और साबुन में स्थानीय कंपनियों से प्रतिस्पर्धा।
Promises0 met · 1 missedRisks4 trackedTranscriptfull text
Research workspace
Focused Modules
Risks
4 risks
Risk Intelligence
Demand weakness in mass segments
View Risks →
Transcript
Full text
Call Transcript
Full transcript text is available on this route.
Read Transcript →Quarter Snapshot
India Organic Volume Growth
4%
+4pp YoY
Organic volume growth in India was 4% in Q2 FY24, reflecting improvement from prior periods.
Indonesia Volume Growth
11%
+11pp YoY
Indonesia delivered 11% volume growth, driven by improved household insecticide efficacy.
A&P Spend as % of Turnover
10%
+200bps YoY
Media spends increased to ~10% of turnover, up 200bps YoY, supporting market share gains.
RCCL Overhead Reduction
30%
-70pp vs erstwhile
Raymond Consumer integration achieved ~30% of erstwhile overheads, ahead of expectations.
What Changed vs Last Quarter
NEW
Full-year guidance on track for organic and acquired businesses
Management expects to achieve the annual guidance for both organic and acquired businesses, with phasing more favorable to Q4 than Q3.
NEW
Steady improvement in EBITDA margins
EBITDA margin of 20% is expected to improve steadily through structural cost reduction actions, particularly from Indonesia and GAUM.
NEW
Africa restructuring to add ~INR 50 crore profit in FY25
Reorganizing East African hair fashion to an asset-light royalty model will eliminate ~INR 500 crore revenue but add ~INR 50 crore profit in FY25.
NEW
Dividend payout ratio ~50% of annual PAT
Board approved INR 5 per share dividend; management targets average payout ratio of about 50% of annual profit after tax.
DROPPED
Nigeria profitability guidance intact
Management expects to pass on cost increases from naira devaluation (NGN 650 to 750) to consumers, keeping EBITDA plus Forex loss line intact.
DROPPED
Raymond portfolio: high single-digit EBITDA margin for FY24
Management reiterated ambition of high single-digit EBITDA margin for the Raymond portfolio on a full-year basis, with improvements from Q2 onwards.
DROPPED
INR 900 crore organic CapEx in India over 18-36 months
Planned investment of INR 900 crore in organic manufacturing CapEx in India for volume growth and logistics, with ~INR 300 crore per year.
DROPPED
Raymond portfolio: flat net sales YoY for FY24
Management maintained guidance of flat net sales year-on-year for the Raymond portfolio, despite downstocking and returns in Q1.
NEW RISK
Demand weakness in mass segments
Management noted a K-shaped recovery with premium doing well but mass segments under pressure, which could impact volume growth.
NEW RISK
Household insecticide share loss to illegal incense sticks
Despite improvement, the category continues to lose share to illegal incense sticks, though the rate of loss has moderated.
NEW RISK
Potential local competition in soaps
An analyst raised the possibility of local players becoming aggressive in soaps; management acknowledged it could be happening in some regions but not a major factor yet.
NEW RISK
Execution risk in Africa restructuring
The move to an asset-light model in East Africa involves one-time costs and non-cash charges; details are still being worked out.
RISK GONE
Nigeria devaluation impact on reported numbers
The naira devaluation from NGN 450 to 750 per USD will optically reduce INR sales growth by ~200bps and complicate P&L reading, though management expects to pass on costs.
RISK GONE
Sustained demand weakness in India
Management noted tough market conditions in India; if demand does not recover, volume growth may slow despite market development investments.
RISK GONE
Raymond integration and margin trajectory
Analyst raised concern about sharp EBITDA loss in Raymond portfolio; management expects improvement but Q2 may still see pain, with full-year high single-digit margin guidance at risk if synergies lag.
RISK GONE
Household insecticides category still early
Management cautioned against declaring victory in HI despite two strong quarters, citing need for more efficacious products and regulatory hurdles for new molecules.
Fast read
Guidance and risk preview
Management expects to achieve the annual guidance for both organic and acquired businesses, with phasing more favorable to Q4 than Q3.
Management noted a K-shaped recovery with premium doing well but mass segments under pressure, which could impact volume growth.
View Risks →